Cerebrolysin

See source wording

into a vein · once daily · for 14 days

Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICUPHASE3 · NCT06052787

“* Temperature management: to maintain normothermia * Glycemic control: to maintain a glucose level of \[140 -180 mg/dl\] * Peptic ulcer prophylaxis: * Deep venous thrombosis (DVT) prophylaxis.”

See source wording

by mouth · weekly

Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)PHASE4 · NCT01822951

“5-10 mg donepezil: 1x5 mg donepezil as 1 tablet per day from TC 1 Day 1 on and 2x5 mg donepezil as 2 tablets from Visit 3- Visit 5, p.o.”

See source wording

into a vein · daily

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's DiseasePHASE2 · NCT00911807

“After four weeks the daily dosage was increased from 5 mg to 10 mg..”

215.2 mg

into a muscle · once daily · for 8 weeks

Cerebrolycin for Treatment of Covid-related Anosmia and AgeusiaPHASE3 · NCT04830943

“Cerebrolysin will be prescribed in a dose of 5 ml ampoule once daily through intramuscular injection (1ml contains 215.2 mg cerebrolysin) for five times per week, for a total of 40 treatments (for 8 weeks), after which the cycle was individually repeated according to the response of the patient to therapy for a maximum of 24 weeks.”

See source wording

by mouth · once daily · for 5 days

Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's PalsyPHASE1, PHASE2 · NCT05821075

“prednisolone 60mg tablet once daily for 5 days then tapering dose.”

25 mg

into a vein · twice daily · for 10 days

Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic StrokePHASE1, PHASE2 · NCT02149875

“Intravenous infusion of 25mg dl-3-n-butylphthalide b.i.d.for 10 days.”

See source wording

rats · into a vein

[The effect of neuroprotectors on the level of BDNF, tumor necrosis factor alpha and apoptosis markers, and in acute cerebrovascular accidents].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2026

“At the onset of reperfusion, animals were administered a single intravenous injection of either saline (control), or Mexidol (ethylmethylhydroxypyridine succinate) intravenously at a dose of 50 mg/kg, or Cerebrolysin intraperitoneally at a dose of 215 mg/kg, or Cortexin intraperitoneally at a dose of 1 mg/kg.”

20 mg/kg

mice · another route · once daily

Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway.Molecular brain · 2025

“Intraperitoneal injection of ketamine was performed at 20 mg/kg for 14 consecutive days.”

See source wording

rats ·

The Role of Cerebrolysin in Promoting Axonal Regeneration and Functional Recovery after Peripheral Nerve Injury: A Focus on Macrophage Activation.Advanced pharmaceutical bulletin · 2025

“Results Results demonstrated that Cerebrolysin, particularly at 5 mg/kg, significantly improved SFI scores and thermal paw withdrawal latency compared to the control group, indicating enhanced functional recovery.”